2021 annual financial data
Cartesian Therapeutics 2021 Operating cash flow margin
Direct answer
Operating cash flow margin was -70.97%.
Operating income was -4,597,000 USD and net income was -25,687,000 USD.
Operating cash flow was -60,382,000 USD.
Get free Cartesian Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 85,077,000 USD
- Operating income
- -4,597,000 USD
- Net income
- -25,687,000 USD
- Operating cash flow
- -60,382,000 USD